Who is sponsoring NCT02452814?

NCT02452814 is sponsored by Hoffmann-La Roche.

What is the status of NCT02452814?

NCT02452814 is currently COMPLETED.

Last reviewed 2018-02-06 · How we verify

Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection

NCT02452814 COMPLETED

Long Term Observational Extension Study Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination with Telaprevir and Ribavirin in Subjects with Chronic Hepatitis C Virus Genotype 1 Infection

Details

Lead sponsor	Hoffmann-La Roche
Status	COMPLETED
Enrolment	8
Start date	Wed May 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed May 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Countries

Puerto Rico, United States